Merlin Biomed Investment Advisor LLC - New York City, New York 10001

Merlin Biomed Investment Advisor LLC is categorized under in New York City, NY .

Business Name: Merlin Biomed Investment Advisor LLC
Contact Person: Stuart Weisbrod
Address: 424 West 33rd St Room 520, New York City, New York 10001
Phone Number: (615) 895-9076
Annual Revenue (USD): $1.000.000 to $2.499.999
Founding Year: 2003
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category:
SIC Code: 6282
NAICS Code: 523930
Share This Business:
Related Businesses: Economatrix Research Assoc - New York City, NY 10001
Genuinealpha Partners LLC - New York City, NY 10001
Preimer Financial Group - New York City, NY 10001
Educational Foundation For The Fashion Industry Inc - New York City, NY 10001
Allen Parker & CO Inc - New York City, NY 10001
Mitan Capital Corp - New York City, NY 10001
Cscout - New York City, NY 10001
Synergy Life Brokerage - New York City, NY 10001
Ameriprise Financial Services Inc - New York City, NY 10001
Georgia Advisors LLC - New York City, NY 10001
Marello Investment Advisors - New York City, NY 10001
Smith Barney Harris Upham & CO - New York City, NY 10001
Smith Barney - New York City, NY 10001
Pnc Global Investment Serv - New York City, NY 10001

The company Merlin Biomed Investment Advisor LLC provides B2B services in the form of from its single location in New York. 1 to 4 employees work for Merlin Biomed Investment Advisor LLC, and the business now earns $1.000.000 to $2.499.999 per annum.

Merlin Biomed Investment Advisor LLC was launched in 2003 and is classified under SIC code and category 6282 , and NAICS number and grouping 523930 . To contact Merlin Biomed Investment Advisor LLC, please call Stuart Weisbrod with the phone number (615) 895-9076 or visit its single location at 424 West 33rd St Room 520 in New York City, New York 10001.

The location of the single location can also be found using the coordinates . Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.